Table 1

Assessment measures at the baseline and follow-up evaluations

Assessment measure	Baseline	Immediate follow-up (week 7 for LMP and week 13 for BBL-GP and active control group)	Week 18	Week 36	Week 62
Screening
APSS	√
MMSE (if 60+)	√
Questionnaires
ANU-ADRI	√	√	√	√	√
PSQI	√	√	√	√	√
ARFS	√	√	√	√	√
SF-12	√	√	√	√	√
MHQ	√
Cognitive measures
Trails A+B	√		√	√	√
DSMT	√		√	√	√
Physical and medical evaluation (by doctors and nurses)
MVPA	√		√	√	√
Blood pressure	√		√	√	√
Height, cm	√
Weight, kg	√		√	√	√
Waist and hip, cm	√		√	√	√
Body composition	√		√	√	√
Framingham CHD	√		√	√	√
AUSDRISK	√		√	√	√

ANU-ADRI, Australian National University—Alzheimer’s Disease Risk Index; APSS, Adults Pre-exercise Screening System; ARFS, Australian Recommended Food Score; AUSDRISK, Australian Type 2 Diabetes Risk Assessment Tool; BBL-GP, Body Brain Life—General Practice; DSMT, Digit Symbol Modalities Test; Framingham CHD, Framingham Coronary Heart Disease Risk Score; LMP, Lifestyle Modification Programme; MHQ, Multidimensional Health Questionnaire; MMSE, Mini-Mental State Examination; MVPA, Moderate–vigorous physical activity; PSQI, Pittsburgh Sleep Quality Index; SF-12, 12-item Short Form Health Survey.